VVUS and OREX will not make it. VVUS could be short-lived. Remember Vioxx?
VVUS right now is in what they refer to as phase 4 trials. After the FDA approves a drug and its prescribed out by physicians, the prescribing doctors in phase 4 have to pay close attention and periodically check there patients for adverse side affects. If too many patients report bad side affects in phase 4, the FDA will immediately pull the drug off the market. The FDA particularly and closely looks for adverse side affects on the cardiovascular system. look it up, ARNA could end up being the only drug on the market for weight-loss in the longer-term.